Gemazocine

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Gemazocine
Systematic (IUPAC) name
10-(cyclopropylmethyl)-1-ethyl-13,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-trien-4-ol
Clinical data
Pregnancy cat.  ?
Legal status  ?
Identifiers
CAS number 54063-47-7
ATC code None
PubChem CID 219096
ChemSpider 189916
Chemical data
Formula C20H29NO 
Mol. mass 299.450 g/mol

Gemazocine (R-15,497), also known as cyclogemine, is an opioid antagonist of the benzomorphan family which was never marketed.[1][2] It has weak partial agonist properties at the opioid receptors but is generally antagonistic in its effects.[3]

See also [edit]

References [edit]

  1. ^ Macdonald, F. (1997). Dictionary of Pharmacological Agents. CRC Press. p. 955. ISBN 978-0-412-46630-4. Retrieved 22 April 2012. 
  2. ^ Gelders, Y. G.; de Ranter, C. J.; Schenk, H. (1979). "Structural Studies of Substituted 6,7-Benzomorphan Compounds. I. The Absolute Configuration of (−)-2-Cyclopropylmethyl-2'-hydroxy-5-ethyl-9,9-dimethyl-6,7-benzomorphan (Gemazocine) Hydrobromide". Acta Crystallographica B 35 (3): 699–703. doi:10.1107/S0567740879004477. 
  3. ^ Freye, E.; Hartung, E.; Schenk, G. K. (1983). "Bremazocine: An Opiate That Induces Sedation and Analgesia without Respiratory Depression" (pdf). Anesthesia and Analgesia 62 (5): 483–488. PMID 6301311.